P2Y12 inhibition should be started at the time of NSTEMI diagnosis - PRO.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Controversies in anti-platelet therapy Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by